H.C. Wainwright analyst Yi Chen downgraded Zynex (ZYXI) to Neutral from Buy without a price target The company reported a Q2 miss and an operational restructuring is in progress, the analyst tells investors in a research note. The firm says there is no visibility at this point as to when Tricare payments to Zynex will resume.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZYXI: